Increased resistance to cis-diamminedichloroplatinum(II) in NIH 3T3 cells transformed by ras oncogenes.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Cancer Research

• Publication date

  1988-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 3276398
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of ras oncogene p21 in prostate cancer.

  1986cited by this paper
• Multidrug resistance.

  1986cited by this paper
• Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.

  1985cited by this paper
• Isolation of activated ras transforming genes from two patients with Hodgkin's disease.

  1985cited by this paper
• NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude mice

  1985cited by this paper
• Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.

  1985cited by this paper
• ras Oncogene p21 expression is increased in premalignant lesions and high grade bladder carcinoma

  1985cited by this paper
• The action of oncogenes in the cytoplasm and nucleus.

  1985cited by this paper
• The HL-60 transforming sequence: a ras oncogene coexisting with altered myc genes in hematopoietic tumors.

  1983cited by this paper
• Structure and activation of the human N-ras gene.

  1983cited by this paper
• McDonough feline sarcoma virus: characterization of the molecularly cloned provirus and its feline oncogene (v-fms)

  1982cited by this paper
• Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene

  1982cited by this paper
• Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus

  1982cited by this paper
• Mechanism of activation of a human oncogene

  1982cited by this paper
• Analysis of two divergent rat genomic clones homologous to the transforming gene of Harvey murine sarcoma virus.

  1981cited by this paper
• Biological activity of cloned Moloney sarcoma virus DNA: Terminally redundant sequences may enhance transformation efficiency.

  1980cited by this paper
• The mechanism of action of antitumor platinum compounds.

  1979cited by this paper
• Transformation of mammalian cells with genes from procaryotes and eucaryotes.

  1979cited by this paper
• Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

  1979cited by this paper
• Detection of specific sequences among DNA fragments separated by gel electrophoresis.

  1975cited by this paper
• A new technique for the assay of infectivity of human adenovirus 5 DNA.

  1973cited by this paper
• Binding of an antitumor platinum compound to cells as influenced by physical factors and pharmacologically active agents.

  1973cited by this paper

• Therapeutic Potential of Metal-Based and PARP Inhibitor Chemotherapy for BRCA1-Associated Triple-Negative Breast Cancer

  2025cites this paper
• Identification of Anti-Inflammatory and Anti-Cancer Compounds Targeting the NF-κB-NLRP3 Inflammasome Pathway from a Phytochemical Library of the Sideritis Genus.

  2024cites this paper
• Key Players of Cisplatin Resistance: Towards a Systems Pharmacology Approach

  2018cites this paper
• Triple-negative breast cancer: investigating potential molecular therapeutic target

  2015cites this paper
• MKP1 mediates chemosensitizer effects of E1a in response to cisplatin in non-small cell lung carcinoma cells

  2015cites this paper
• Enhanced MET Translation and Signaling Sustains K-Ras-Driven Proliferation under Anchorage-Independent Growth Conditions.

  2015cites this paper
• Identification of cellular and molecular factors determining the response of cancer cells to six ergot alkaloids

  2015cites this paper
• Treatment-interval associated effect of irradiation on locoregionally-relapsed ovarian cancer.

  2014cites this paper
• Inhibition of ATP-Binding Cassette Transporters by Chinese Herbs and Phytochemicals

  2013cites this paper
• KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma

  2013cites this paper
• Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy.

  2013cites this paper
• P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs.

  2012cites this paper
• Comparison of ERCC1/XPF genetic variation, mRNA and protein levels in women with advanced stage ovarian cancer treated with intraperitoneal platinum.

  2012cites this paper
• Invited Review Tumor heterogeneity: morphological, molecular and clinical implications

  2011cites this paper
• Molecular characterization of the in vivo alkylating agent resistant murine EMT-6 mammary carcinoma tumors

  2009cites this paper
• The A / J Mouse Lung as a Model for Developing New Chemointervention Strategies

  2007cites this paper
• Targeting inhibition of K-ras enhances Ad.mda-7-induced growth suppression and apoptosis in mutant K-ras colorectal cancer cells

  2007cites this paper
• Vascularity, perfusion rate and local tissue oxygenation of tumors derived from rus‐transformed fibroblasts

  2007cites this paper
• Prochownik myc Erythroleukemia Cells by c-- Platinum Resistance in Friend cis Modulation of Updated Version

  2006cites this paper
• Resistance Patterns between m-Diamminedichloroplatinum(H) and Ionizing Radiation1

  2006cites this paper
• Modulation of m-Platinum Resistance in Friend Erythroleukemia Cells by c-myc 1

  2006cites this paper
• Loss of cw-Diamminedichloroplatinum(H) Resistance in Human Ovarian Carcinoma Cells Selected for Rhodamine 123 Resistance1

  2006cites this paper
• K-ras mutations in non-small-cell lung carcinoma: a review.

  2006cites this paper
• Oncogenes and Tumor Suppressor Genes in Therapeutic Resistance

  2006cites this paper
• Prognostic role of K-Ras mutations in non-small cell lung cancer: still an issue for open debate.

  2006cites this paper
• Modulation of cellular chemoresistance in keratinocytes by activation of different oncogenes

  2006cites this paper
• Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines.

  2005cites this paper
• Differences in effects of oncogenes on sensitivity to anticancer drugs.

  2005cites this paper
• Role of protein kinases in antitumor drug resistance

  2005cites this paper
• Expression of apoptosis-related oncoproteins and modulation of apoptosis by caffeine in human leukemic cells

  2005cites this paper
• Protect Cells from Platinum-Based Anticancer Agents Oncogenic HRas UpRegulates Expression of ERCC 1 to Updated

  2004cites this paper
• Ras oncogene point mutations in bladder cancer resistant to cisplatin

  2004cites this paper
• In vitro effect of liposome-incorporated valinomycin on growth and macromolecular synthesis of normal and ras-transformed 3T3 cells

  2004cites this paper
• Chemotherapeutic drug resistance in the management of head and neck cancer

  2004cites this paper
• Cell-signaling targets for antitumour drug development

  2004cites this paper
• Molecular Determinants of the Cytotoxicity of Platinum Compounds

  2004cites this paper
• CHAPTER 36 – Ovarian Carcinogenesis

  2004cites this paper
• Oncogenic H-Ras Enhances DNA Repair through the Ras/Phosphatidylinositol 3-Kinase/Rac1 Pathway in NIH3T3 Cells

  2002cites this paper
• Trimodality treatment in Stage III nonsmall cell lung carcinoma

  2002cites this paper
• Ki‐ras mutation type and the survival benefit from adjuvant chemotherapy in Dukes' C colorectal cancer

  2001cites this paper
• Prognostic value of K-ras mutations and allelic imbalance on chromosome 18q in patients with resected colorectal cancer

  2001cites this paper
• DNA topoisomerases as targets for anticancer drugs

  2001cites this paper
• Prenyltransferase Inhibitors as Radiosensitizers

  2001cites this paper
• Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial.

  2001cites this paper
• Antisense Cyclin D1 Enhances Sensitivity of Head and Neck Cancer Cells to Cisplatin

  2001cites this paper
• Mechanisms of resistance to cisplatin.

  2001cites this paper
• Increased apoptosis and increased clonogenic survival of 12V-H-ras transformed rat fibroblasts in response to cisplatin

  2000cites this paper
• Tumor heterogeneity: morphological, molecular and clinical implications.

  2000cites this paper
• Impact of viral oncogenesis on responses to anti-cancer drugs and irradiation.

  2000cites this paper
• Ki‐ras activation in vitro affects G1 and G2M cell‐cycle transit times and apoptosis

  2000cites this paper
• CLINICAL APPLICATION OF CHEMOSENSITIVITY TEST USING HISTOCULTURE DRUG RESPONSE ASSAY FOR ADVANCED ESOPHAGEAL CANCER

  2000cites this paper
• Cisplatin resistance and oncogenes - a review

  2000cites this paper
• Restricted 12p amplification and RAS mutation in human germ cell tumors of the adult testis.

  2000cites this paper
• v‐src induces cisplatin resistance by increasing the repair of cisplatin–DNA interstrand cross‐links in human gallbladder adenocarcinoma cells

  1999cites this paper
• Molecular aspects of ovarian cancer. Is gene therapy the solution?

  1999cites this paper
• Apoptosis induction and inhibition of H-ras overexpression by novel trans-[PtCl2(isopropylamine)(amine')] complexes.

  1999cites this paper
• Radiosensitization of human tumor cell lines induced by the adenovirus-mediated expression of an anti-Ras single-chain antibody fragment.

  1999cites this paper
• Preferential repair of the N-ras gene in K 562 cells after exposure to cisplatin.

  1999cites this paper
• Determinants in chemosensitivity of oncogene-transformed NIH3T3 cells to 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosylcytosine.

  1999cites this paper
• Synthesis and characterization of Pd(II) and Pt(II) complexes of p-isopropylbenzaldehyde N-protected thiosemicarbazones. Cytotoxic activity against ras-transformed cells.

  1999cites this paper
• Investigation of multidrug resistance and invasion in human cancer cell lines

  1999cites this paper
• Cytotoxicity, apoptosis, and in vitro DNA damage induced by potassium chromate.

  1999cites this paper
• Estrogen Inducibility of c-Ha-ras Transcription in Breast Cancer Cells

  1999cites this paper
• Resistance to cisplatin.

  1999cites this paper
• Intracellular expression of an antibody fragment-neutralizing p21 ras promotes tumor regression.

  1998cites this paper
• Cisplatin induced intermediate filament reorganization and altered mitochondrial function in 3T3 cells and drug-sensitive and -resistant Walker 256 cells.

  1998cites this paper
• Cisplatin-induced activation of murine bone marrow-derived macrophages require protein tyrosine phosphorylation.

  1998cites this paper
• Clinical implications of molecular abnormalities in lung cancer.

  1998cites this paper
• Prognostic value of K-ras mutations, ras oncoprotein, and c-erb B-2 oncoprotein expression in adenocarcinoma of the lung.

  1998cites this paper
• Second primary cancers after resection of lung adenocarcinoma with ras gene mutation.

  1998cites this paper
• ras mutation and platinum resistance in human ovarian carcinomas in vitro

  1998cites this paper
• Cisplatin Induction of ERCC-1 mRNA Expression in A2780/CP70 Human Ovarian Cancer Cells*

  1998cites this paper
• Molecular abnormalities in lung cancer.

  1998cites this paper
• Modulation of cytotoxicity of chemotherapeutic drugs by activated H-ras.

  1997cites this paper
• Role of ras oncogene in adriamycin resistance in human prostate tumor cells.

  1997cites this paper
• Characterization of human breast adenocarcinoma SK-BR-3 cells resistant to doxorubicin.

  1997cites this paper
• MULTIDRUG RESISTANCE IN LEUKAEMIA

  1997cites this paper
• Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study.

  1997cites this paper
• The erbB 2 oncogene and chemotherapy: a mini-review.

  1997cites this paper
• Decreased sensitivity of carcinoembryonic antigen cDNA‐transfected cells to adriamycin

  1997cites this paper
• Correlation of MDR1 expression and oncogenic activation in human epithelial ovarian carcinoma.

  1997cites this paper
• Correlation between K‐ras gene mutation and prognosis of patients with nonsmall cell lung carcinoma

  1997cites this paper
• K-ras mutations in patients with early colorectal cancers

  1997cites this paper
• Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines.

  1997cites this paper
• Effect of cisplatin exposure on the degree of N-myc amplification in small cell lung carcinoma cell lines with N-myc amplification.

  1996cites this paper
• Correlation of the response to cisplatin of human ovarian cancer cell lines, originating from one tumor but with different sensitivity, with the recovery of DNA adducts.

  1996cites this paper
• Selective drug efflux in multidrug-resistant immunoblastic B lymphoma cells with overexpressed P-glycoprotein.

  1996cites this paper
• Detection of K-ras gene mutations in non-neoplastic lung tissue and lung cancers.

  1996cites this paper
• Molecular basis of cis-diamminedichloroplatinum(II) resistance: a review.

  1996cites this paper
• Three‐dimensional cell culture induces novel proliferative and metabolic alterations associated with oncogenic transformation

  1996cites this paper
• Species-specific differences in taxol transport and cytotoxicity against human and rodent tumor cells. Evidence for an alternate transport system.

  1996cites this paper
• Insights into Mechanisms of Cisplatin Resistance and Potential for Its Clinical Reversal

  1996cites this paper
• Different mechanisms are responsible for c‐jun mRNA induction by cisplatin and ultraviolet light

  1996cites this paper
• Ras inhibitors.

  1996cites this paper
• New prognostic factors in resectable non-small cell lung cancer.

  1996cites this paper
• Oncogenic transformation alters cisplatin‐induced apoptosis in rat embryo fibroblasts

  1995cites this paper
• Sensitivity of anticancer drugs in NIH3T3' cells transfected with oncogenes accompanied by pSV2neo vector.

  1995cites this paper
• Lack of elevated drug efflux in adriamycin‐resistant immunoblastic B lymphoma cells with mdr1 overexpression

  1995cites this paper
• High incidence of point mutation in K‐ras codon12 in carcinoma of the fallopian tube

  1995cites this paper
• Resistance to cytosine arabinoside in cells transfected with activated Ha-ras oncogene.

  1995cites this paper